139 related articles for article (PubMed ID: 10729371)
1. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys.
Kishioka S; Paronis CA; Lewis JW; Woods JH
Eur J Pharmacol; 2000 Mar; 391(3):289-97. PubMed ID: 10729371
[TBL] [Abstract][Full Text] [Related]
2. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
Butelman ER; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
[TBL] [Abstract][Full Text] [Related]
3. Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys.
Briscoe RJ; Winger G; Lewis JW; Woods JH
Psychopharmacology (Berl); 2000 Mar; 148(4):393-9. PubMed ID: 10928312
[TBL] [Abstract][Full Text] [Related]
4. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
[TBL] [Abstract][Full Text] [Related]
5. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
Pitts RC; Allen RM; Walker EA; Dykstra LA
J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
[TBL] [Abstract][Full Text] [Related]
6. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
Gerak LR; Maguire DR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Feb; 368(2):229-236. PubMed ID: 30463875
[TBL] [Abstract][Full Text] [Related]
7. 3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.
Husbands SM; Sadd J; Broadbear JH; Woods JH; Martin J; Traynor JR; Aceto MD; Bowman ER; Harris LS; Lewis JW
J Med Chem; 1998 Aug; 41(18):3493-8. PubMed ID: 9719602
[TBL] [Abstract][Full Text] [Related]
8. Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys.
Minervini V; Disney A; Husbands SM; France CP
Psychopharmacology (Berl); 2020 Oct; 237(10):3057-3065. PubMed ID: 32772146
[TBL] [Abstract][Full Text] [Related]
9. Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys.
Kishioka S; Paronis CA; Woods JH
Eur J Pharmacol; 2000 Jun; 398(1):121-30. PubMed ID: 10856456
[TBL] [Abstract][Full Text] [Related]
10. Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys.
Butelman ER; Negus SS; Lewis JW; Woods JH
Psychopharmacology (Berl); 1996 Feb; 123(4):320-4. PubMed ID: 8867870
[TBL] [Abstract][Full Text] [Related]
11. Opioid partial agonist effects of 3-O-methylnaltrexone in rhesus monkeys.
Platt DM; Rowlett JK; Izenwasser S; Spealman RD
J Pharmacol Exp Ther; 2004 Mar; 308(3):1030-9. PubMed ID: 14634035
[TBL] [Abstract][Full Text] [Related]
12. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
Liguori A; Morse WH; Bergman J
J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
[TBL] [Abstract][Full Text] [Related]
13. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
[TBL] [Abstract][Full Text] [Related]
14. Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys.
Maguire DR; Gerak LR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Jan; 368(1):88-99. PubMed ID: 30401680
[TBL] [Abstract][Full Text] [Related]
15. Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse.
Woods JH; Lewis JW; Winger G; Butelman E; Broadbear J; Zernig G
NIDA Res Monogr; 1995; 147():195-219. PubMed ID: 8742788
[No Abstract] [Full Text] [Related]
16. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
17. Acute and prolonged effects of clocinnamox and methoclocinnamox on nucleus accumbens dopamine overflow.
Zernig G; Fibiger HC
Psychopharmacology (Berl); 1998 Jan; 135(1):17-21. PubMed ID: 9489929
[TBL] [Abstract][Full Text] [Related]
18. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
19. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine.
Negus SS; Brandt MR; Gatch MB; Mello NK
Drug Alcohol Depend; 2003 May; 70(1):17-27. PubMed ID: 12681522
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.
Kishioka S; Ko MC; Woods JH
Eur J Pharmacol; 2000 May; 397(1):85-92. PubMed ID: 10844102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]